Compounds > dihydrotetrabenazine
Page last updated: 2024-09-03

dihydrotetrabenazine and paroxetine

dihydrotetrabenazine has been researched along with paroxetine in 5 studies

Compound Research Comparison

Studies
(dihydrotetrabenazine)		Trials
(dihydrotetrabenazine)		Recent Studies (post-2010)
(dihydrotetrabenazine)		Studies
(paroxetine)		Trials
(paroxetine)		Recent Studies (post-2010) (paroxetine)
2344604,2571,0311,031

Protein Interaction Comparison

ProteinTaxonomydihydrotetrabenazine (IC50)paroxetine (IC50)
Voltage-dependent L-type calcium channel subunit alpha-1FHomo sapiens (human)3.9
MyeloperoxidaseHomo sapiens (human)0.02
Aldo-keto reductase family 1 member B1Rattus norvegicus (Norway rat)0.086
Muscarinic acetylcholine receptor M2Homo sapiens (human)0.532
Muscarinic acetylcholine receptor M4Homo sapiens (human)0.244
Muscarinic acetylcholine receptor M5Homo sapiens (human)0.123
Quinolone resistance protein NorAStaphylococcus aureus7
Cytochrome P450 2D6Homo sapiens (human)0.5003
Muscarinic acetylcholine receptor M1Homo sapiens (human)0.145
Muscarinic acetylcholine receptor M3Homo sapiens (human)0.179
Beta-adrenergic receptor kinase 1Bos taurus (cattle)1.08
Sodium-dependent noradrenaline transporter Homo sapiens (human)0.093
Sodium-dependent dopamine transporterRattus norvegicus (Norway rat)0.623
Beta-adrenergic receptor kinase 1Homo sapiens (human)1.24
Substance-P receptorHomo sapiens (human)0.9
Sodium-dependent serotonin transporterHomo sapiens (human)0.0007
Sodium-dependent serotonin transporterRattus norvegicus (Norway rat)0.0003
P2X purinoceptor 4Rattus norvegicus (Norway rat)2.45
Voltage-dependent L-type calcium channel subunit alpha-1D Homo sapiens (human)3.9
Sodium-dependent dopamine transporter Homo sapiens (human)0.672
Voltage-dependent L-type calcium channel subunit alpha-1SHomo sapiens (human)3.9
Voltage-dependent L-type calcium channel subunit alpha-1CHomo sapiens (human)3.9
P2X purinoceptor 4Homo sapiens (human)2.8067
Sigma non-opioid intracellular receptor 1Homo sapiens (human)5.366
TransporterRattus norvegicus (Norway rat)0.535

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's3 (60.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alouf, JE; Buckle, M; Cesura, A; Da Prada, M; Geoffroy, C; Launay, JM; Mutel, V1
Bertocci, B; Cesura, AM; Da Prada, M1
Costentin, J; Leroux-Nicollet, I; Naudon, L; Raisman-Vozari, R; Vilpoux, C1
Rehavi, M; Roz, N; Weizman, A1
Anderson, LL; Cozzi, NV; Daley, PF; Feih, JT; Gopalakrishnan, A; Ruoho, AE; Shulgin, AT1

Other Studies

5 other study(ies) available for dihydrotetrabenazine and paroxetine

ArticleYear
One-step purification of the serotonin transporter located at the human platelet plasma membrane.
    The Journal of biological chemistry, 1992, Jun-05, Volume: 267, Issue:16

    Topics: Biological Transport; Blood Platelets; Blood Proteins; Carrier Proteins; Cell Membrane; Chromatography, Affinity; Electrophoresis, Gel, Two-Dimensional; Electrophoresis, Polyacrylamide Gel; Humans; Ouabain; Paroxetine; Piperidines; Serotonin; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Tetrabenazine

1992
Binding of [3H]dihydrotetrabenazine and [125I]azidoiodoketanserin photoaffinity labeling of the monoamine transporter of platelet 5-HT organelles.
    European journal of pharmacology, 1990, Sep-04, Volume: 186, Issue:1

    Topics: Affinity Labels; Animals; Azides; Biogenic Monoamines; Blood Platelets; Blood Proteins; Cell Membrane; Guinea Pigs; Humans; In Vitro Techniques; Iodine Radioisotopes; Ketanserin; Paroxetine; Photochemistry; Piperidines; Rabbits; Rats; Receptors, Serotonin; Subcellular Fractions; Tetrabenazine

1990
Reserpine or chronic paroxetine treatments do not modify the vesicular monoamine transporter 2 expression in serotonin-containing regions of the rat brain.
    Neuropharmacology, 2000, Apr-03, Volume: 39, Issue:6

    Topics: Animals; Autoradiography; Binding Sites; Biological Transport; Brain; Citalopram; Dopamine; Immunohistochemistry; In Situ Hybridization; In Vitro Techniques; Ligands; Male; Membrane Glycoproteins; Membrane Transport Proteins; Neuropeptides; Norepinephrine; Paroxetine; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Reserpine; Selective Serotonin Reuptake Inhibitors; Serotonin; Tetrabenazine; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins

2000
Chronic clozapine, but not haloperidol, treatment affects rat brain vesicular monoamine transporter 2.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2002, Volume: 12, Issue:3

    Topics: Animals; Antipsychotic Agents; Binding Sites; Biological Transport; Brain; Brain Chemistry; Clozapine; Drug Administration Schedule; Fluoxetine; Haloperidol; In Situ Hybridization; Male; Membrane Glycoproteins; Membrane Transport Proteins; Neuropeptides; Paroxetine; Piperazines; Rats; Tetrabenazine; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins

2002
Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter.
    Journal of neural transmission (Vienna, Austria : 1996), 2009, Volume: 116, Issue:12

    Topics: Animals; Blood Platelets; Cell Line; Hallucinogens; Humans; N,N-Dimethyltryptamine; Paroxetine; Rats; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Spodoptera; Tetrabenazine; Tritium; Tryptamines; Vesicular Monoamine Transport Proteins

2009